Related Experiment Video
Updated: Apr 11, 2026
12:08
Improving IV Insulin Administration in a Community Hospital
Published on: June 11, 2012
19.5K
Development of the OnTrack Diabetes Program.
Mandy Cassimatis1, David J Kavanagh, Andrew P Hills
1Queensland University of Technology, Institute of Health and Biomedical Innovation, Brisbane, Australia. mandy.cassimatis@usq.edu.au.
JMIR Research Protocols
|May 28, 2015
Summary
OnTrack Diabetes is a new web-based program designed to help people with Type 2 diabetes manage their condition. This self-guided tool aims to improve physical and emotional well-being for better diabetes self-management.
Area of Science:
- Digital health interventions
- Behavioral medicine
- Chronic disease management
Background:
- Type 2 diabetes affects millions globally, leading to severe complications.
- Dysphoria is common in diabetes and worsens glycemic control.
- Accessible, cost-effective support for diabetes self-management is limited, especially in remote areas.
Purpose of the Study:
- To describe the development of OnTrack Diabetes, a self-guided, web-based program.
- To promote emotional well-being (euthymia) and improve disease self-management in Type 2 diabetes patients.
Main Methods:
- Semistructured interviews with general practitioners and Type 2 diabetes patients informed program design.
- Content development utilized existing research and resources.
- Program features were adapted from an existing OnTrack program for cost-effectiveness and self-guided delivery.
Main Results:
- The development phase focused on creating an acceptable and user-friendly program.
- A separate paper details the protocol for a randomized controlled trial to evaluate the program's effectiveness.
Conclusions:
- The OnTrack Diabetes program development incorporated strategies for user acceptability.
- Future research will involve user experience testing and randomized controlled trials to assess effectiveness and cost-effectiveness.
Related Concept Videos
01:15Diabetes: Management and Pharmacotherapy
1.5K
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
1.5K
01:22Diabetes Mellitus: Type 2 and Gestational
5.8K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
5.8K
01:20Pathophysiology of Diabetes
4.5K
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
4.5K
01:22Diabetes Mellitus: Overview and Type I Subtype
6.3K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
6.3K
01:15Diabetes: Symptoms, Diagnosis, and Complications
2.9K
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
2.9K
01:11Clinical Trials: Overview
5.5K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
5.5K